Is It Time To Re-Think Autism?
By Joe Shute,
The Telegraph
| 09. 23. 2015
When Daniel Tammet was three years old, he fell down the stairs of the terraced family home he shared with his parents in Dagenham. It is his earliest memory, not just for the pain of the bumps and bruises, but because as he tumbled he could see golden sparks falling all around him. In later years, he started to experience occasional seizures; and whenever somebody shouted he would see the colour blue.
“At school I just always thought in a different way,” he says. “The other children didn’t understand me but luckily I had good teachers and a library I could go to.”
To date, Tammet (who was diagnosed with high-functioning autism in 2004, at the age of 25) has written four books (including his memoirs, neuroscience, and a collection of essays on maths) and sold more than a million copies. His writing is translated into 23 languages, 10 of which he himself can speak. Yet what most of us perceive to be simple social skills like displaying empathy and talking to strangers, Tammet admits, have been far more...
Related Articles
By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026
"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of the century." This is how Lucas Harrington explained the goal of his company Preventive: to create genetically modified babies. Trying...
By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026
This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...
By Laura Hughes, Financial Times | 05.20.2026
Sophie and her husband are set to spend more than £100,000 in travel and medical bills as they fly between England and the US in their bid to have another child.
The couple are undergoing IVF treatment in New York...
By Rebecca Roberts, The Scientist | 05.19.2026
Scientists have had prenatal gene therapy in their sights for decades; by treating the fetus in utero, they can potentially prevent the long-term damage caused by severe, early-onset genetic disorders. Despite its success in preclinical studies, the method has...